Inflammation-targeted delivery of probiotics for alleviation of colitis and associated cognitive disorders through improved vitality and colonization
Authors:
- 1 February 2025
- journal article
- Published by Elsevier in Biomaterials
- Vol. 318, 123163
Abstract
No abstract availableKeywords
Funding Information
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
This publication has 48 references indexed in Scilit:
- A Gas Therapy Strategy for Intestinal Flora Regulation and Colitis Treatment by Nanogel‐Based Multistage NO Delivery MicrocapsulesAdvanced Materials, 2024
- Oral chondroitin sulfate functionalized natural polyphenol for targeted therapy of ulcerative colitisMaterials & Design, 2024
- Oral Delivery of Transformable Bilirubin Self‐Assembled System for Targeted Therapy of ColitisAdvanced Healthcare Materials, 2023
- Wielding the double-edged sword: Redox drug delivery systems for inflammatory bowel diseaseJournal of Controlled Release, 2023
- Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategiesMaterials Today Bio, 2023
- Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel diseaseBiomaterials, 2022
- Redox-active nanoparticles for inflammatory bowel diseaseNano Research, 2021
- Bile Acids: A Communication Channel in the Gut-Brain AxisNeuroMolecular Medicine, 2020
- A Proresolving Peptide Nanotherapy for Site‐Specific Treatment of Inflammatory Bowel Disease by Regulating Proinflammatory Microenvironment and Gut MicrobiotaAdvanced Science, 2019
- Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's diseaseGastroenterology, 1998